ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SLXP (MM)

172.96
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
(MM) NASDAQ:SLXP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 172.96 0 01:00:00

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Salix Pharmaceuticals, Ltd. And Encourag...

28/02/2015 10:00am

Business Wire


Salix (NASDAQ:SLXP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Salix Charts.

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Salix Pharmaceuticals, Ltd. (“Salix” or the “Company”) (Nasdaq: SLXP) relating to the proposed buyout of the Company by Valeant Pharmaceuticals International, Inc. (“Valeant”).

On February 22, 2015, Salix and Valeant announced the signing of a definitive agreement pursuant to which Valeant will acquire Salix in a transaction valued at approximately $14.5 billion.

Under the terms of the transaction, Salix shareholders are anticipated to receive $158.00 in cash for each share of Salix common stock held. The transaction is expected to close, in the second quarter of 2015, though Salix shareholders will most likely be asked to vote on the transaction well before that time.

The firm’s investigation seeks to determine, among other things, whether the Company’s Board of Directors failed to satisfy their duties to shareholders, including whether the Board adequately pursued alternatives to the acquisition and whether the Board obtained the best price possible for the Company’s shares of common stock. In particular, according to Yahoo! Finance, at least one Wall Street analyst has issued a price target for Salix stock at $185.00 per share.

If you currently own common stock of Salix and would like to learn more about the investigation being conducted by Brower Piven, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentinvestigations.html. You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.

Brower Piven, A Professional CorporationCharles J. Piven, 410-415-66161925 Old Valley RoadStevenson, Maryland 21153hoffman@browerpiven.com

1 Year Salix Chart

1 Year Salix Chart

1 Month Salix Chart

1 Month Salix Chart

Your Recent History

Delayed Upgrade Clock